{
    "title": "Botox rival from Revance gets U.S. approval",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11193329/U-S-FDA-approves-Revances-wrinkle-treatment.html",
    "date": "2022-09-08",
    "keywords": [
        "injection",
        "botox",
        "revance",
        "market",
        "drug",
        "leo",
        "daxxify",
        "year",
        "use",
        "food",
        "administration",
        "challenger",
        "leader",
        "study",
        "httpswwwreuterscomarticleusrevancebotoxiduskbn1e72mu",
        "severity",
        "developer",
        "outcome",
        "share",
        "ability",
        "executive",
        "officer",
        "mark",
        "foley",
        "conference",
        "call",
        "companys",
        "product",
        "access",
        "form",
        "botulinum",
        "toxin",
        "medicine",
        "hit",
        "baby",
        "generation",
        "launch",
        "half",
        "abbvie",
        "purchase",
        "httpswwwreuterscomarticleusallerganmaabbvieiduskcn1tq15x",
        "migraine",
        "price",
        "competition",
        "volume",
        "durability",
        "cowen",
        "analyst",
        "cacciatore",
        "size",
        "survey",
        "bengaluru",
        "writing",
        "banerjee",
        "editing",
        "anil",
        "dsilva"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}